Edwards Lifesciences (EW) Interest & Investment Income (2010 - 2026)

Edwards Lifesciences' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $33.5 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 8.22% year-over-year to $33.5 million; the TTM figure through Mar 2026 stood at $165.8 million (up 18.18% YoY), while the FY2025 annual figure was $168.8 million, up 40.32% from the prior year.
• Interest & Investment Income was $33.5 million for Q1 2026 at Edwards Lifesciences, down from $56.3 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $64.0 million in Q4 2024 to a low of $15.5 million in Q2 2024.
• Historically, Interest & Investment Income has averaged $35.8 million across 3 years, with a median of $36.5 million in 2025.
• Biggest YoY gain for Interest & Investment Income was 141.29% in 2025; the steepest drop was 12.03% in 2025.
• A 3-year view of Interest & Investment Income shows it stood at $64.0 million in 2024, then slipped by 12.03% to $56.3 million in 2025, then sank by 40.5% to $33.5 million in 2026.
• The last three Interest & Investment Income figures came in at $33.5 million (Q1 2026), $56.3 million (Q4 2025), and $38.6 million (Q3 2025), per Business Quant data.